Live Cell Imaging Market worth $5.45BN by 2019, According to a New Study on ASDReports

Monday 18 May 2015, Amsterdam

Market Research Report Press Release The “Live Cell Imaging Market by Product (Equipment, Consumables, Software), by Technology (Fluorescence Recovery after Photobleaching, High-Content Screening), by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019”, analyzes and studies the major market drivers, restraints, challenges, and opportunities.

This report, now available on ASDReports, studies the global live cell imaging market for the forecast period of 2014 to 2019. This market is expected to reach $5.45 Billion by 2019 from $3.57 Billion in 2014, at a CAGR of 8.8% during the forecast period (2014 to 2019).

The global live cell imaging market is segmented on the basis of products, technologies, applications, and regions.

Based on products, the live cell imaging market is categorized into equipment, consumables, and software. In 2014, the equipment segment accounted for a major share of the live cell imaging market. On the basis of equipment, the live cell imaging market is further segmented into microscopes, standalone systems, cell analyzers, and image-capturing devices. In 2014, the microscopy segment accounted for the largest share of the live cell imaging equipment market. Based on consumables, the live cell imaging market is segmented into assay kits, reagents, media, and others. In 2014, the assay kits segment accounted for the largest share of the consumables market.

Based on technologies, the live cell imaging market is segmented into fluorescence resonance energy transfer (FRET), fluorescence in situ hybridization (FISH), high-content analysis (HCA), fluorescence recovery after photobleaching (FRAP), ratiometric imaging, total internal reflection fluorescence microscopy (TRIF), multiphoton excitation microscopy (MPE), and other technologies.

Based on applications, the live cell imaging market is segmented into cell biology, stem cells, developmental biology, and drug discovery. In 2014, the cell biology segment accounted for the largest share of live cell imaging market.

On the basis of regions, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). The Rest of the World region comprises Latin America, Pacific countries, and the Middle East and Africa. In 2014, North America accounted for the largest share of the live cell imaging market, followed by Europe and Asia.

Factors driving this market include adoption of high-content screening techniques in drug discovery, rising incidence of cancer worldwide, and government funding in cell-based research. However, factors such as high cost of high-content screening systems and shortage of knowledgeable and skilled professionals are hindering the growth of this market.

Some of the major players in the global live cell imaging market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc. (U.S.).
Live Cell Imaging Market - Analysis & Global Forecast to 2019

Live Cell Imaging Market - Analysis & Global Forecast to 2019

Publish date : May 2015
Report code : ASDR-195974
Pages : 193

Live Cell Imaging Market - Global Forecasts to 2023

Live Cell Imaging Market - Global Forecasts to 2023

Publish date : February 2019
Report code : ASDR-480237
Pages : February 2019

ASDReports.com Media contact: S. Koopman - Marketing and Communications

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216 - E : stefan.koopman@asdreports.com

 back to News